1998
DOI: 10.1002/(sici)1097-010x(199809/10)282:1/2<32::aid-jez7>3.0.co;2-o
|View full text |Cite
|
Sign up to set email alerts
|

Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(6 citation statements)
references
References 88 publications
0
6
0
Order By: Relevance
“…In the MOG peptide-EAE mice, we have previously shown that the proportion of motor neurons that displayed perikaryal hypoP-NF-H immunoreactivity falls to a lower level than in control mice by day 21 post-MOG peptide [11]. We now show that in those mice with the greatest clinical deficits, occasional motor neurons show accumulations of perikaryal hyperP-NF-H immunoreactivity like those observed in humans with amyotrophic lateral sclerosis [45,48,50] and mice expressing a familial amyotrophic lateral sclerosis mutant superoxide dismutase transgene [51]. However, this was not a consistent finding and should not replace the use of antibodies recognizing hypo-P-NF-H which consistently detects perturbations in both axons and perikarya in our paradigm (this paper and Ref.…”
Section: Discussionmentioning
confidence: 99%
“…In the MOG peptide-EAE mice, we have previously shown that the proportion of motor neurons that displayed perikaryal hypoP-NF-H immunoreactivity falls to a lower level than in control mice by day 21 post-MOG peptide [11]. We now show that in those mice with the greatest clinical deficits, occasional motor neurons show accumulations of perikaryal hyperP-NF-H immunoreactivity like those observed in humans with amyotrophic lateral sclerosis [45,48,50] and mice expressing a familial amyotrophic lateral sclerosis mutant superoxide dismutase transgene [51]. However, this was not a consistent finding and should not replace the use of antibodies recognizing hypo-P-NF-H which consistently detects perturbations in both axons and perikarya in our paradigm (this paper and Ref.…”
Section: Discussionmentioning
confidence: 99%
“…Abnormal accumulation of intermediate filaments (IF) in the perikarya and proximal axons of motor neurons is a common pathological hallmark of ALS, suggesting that abnormalities in neurofilament organization may be involved in the pathogenesis of ALS (180). Neurofilaments are the principal intermediate filament type expressed by motor neurons.…”
Section: Neurofilamentsmentioning
confidence: 99%
“…In addition to the normal catalytic function of SOD1, there is evidence for a gain-of-function toxicity of SOD1 upon mutation. , Proteinaceous inclusions rich in mutant SOD1 are in tissues of ALS-SOD1 transgenic mice and ALS patients and in cell-culture models. , The fibrils or insoluble inclusions in ALS, however, are unlikely to be toxic because they arise in a relatively late stage of the disease . The ALS-inducing SOD1 mutants manifest a common shift of the folding equilibrium toward denatured and partially unfolded apo monomers, either disrupting the dimer interface, perturbing the monomer structure, or compromising the formation of mature (e.g., holo, disulfide-bonded) dimers. Extensive studies show that the immature forms of SOD1, obtainable through intramolecular disulfide reduction, metal-ion removal, , heating, , and chemical induction, , readily form aggregates under physiological conditions, possibly owing to a decrease in the native SOD1 stability and/or an increase in the unfolding rates.…”
mentioning
confidence: 99%